Drug screening targeting TREM2-TYROBP transmembrane binding
M. Cobas-Carreño, Álvaro Esteban-Martos, Laura Tomás‐Gallardo, Íñigo Iribarren, Laura Gonzalez-Palma, Alberto Rivera-Ramos, J. Elena-Guerra, Emilio Alarcón‐Martín, Rocío Ruiz, María José Bravo, Jose Luis Venero, Xavier Morató, Agustı́n Ruiz, José Luís Royo
The paper screens FDA-approved drugs to identify modulators of the TREM2-TYROBP transmembrane interaction, finding varenicline as a potential agonist.
Molecular Medicine · May 5, 2025Peer-reviewedMolecular Biology